(RTTNews) - Sanofi (SNYNF, SNY) said the company's Influenza Vaccines - Fluzone High-Dose Quadrivalent and Flublok Quadrivalent - were among the flu vaccines preferentially recommended by The Centers for Disease Control and Prevention ACIP for adults 65+ in its Morbidity and Mortality Weekly Report.
Michael Greenberg, North America Medical Head of Vaccines at Sanofi, said: "While the ACIP's guidance is a good first step, as a leader in flu vaccines, we believe more can be done to provide healthcare providers with additional guidance."
For More Such Health News, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
